Private Label Bakuchiol Retinol Serum Manufacturer USA

What are the key regulatory and labeling requirements for a private label bakuchiol retinol serum in the USA?

By Blake Mereby · Last reviewed October 4, 2026

A private label bakuchiol retinol serum sold in the USA must comply with FDA cosmetic regulations under 21 CFR Part 700, including accurate ingredient listing, appropriate warning statements for retinol, substantiated marketing claims, and proper classification as either a cosmetic or a drug (retinol serums are cosmetics unless you claim drug benefits like "reduces fine lines medically" or "treats acne as a drug"). The label must list all ingredients in descending order of weight using INCI (International Nomenclature of Cosmetic Ingredients) names, disclose the retail distributor's name and address on the principal display panel, and include a warning statement specifically for retinol, such as "May cause redness, peeling, or irritation. Avoid contact with eyes. Use sunscreen during the day. If irritation develops, reduce frequency of use or discontinue."

The ingredient listing is the most critical regulatory element. Bakuchiol must be listed as "Babchi Extract" or "Bakuchiol" (INCI name), and retinol or retinyl palmitate must be listed with its proper INCI name (not "pro-vitamin A" or "vitamin A derivative" unless that is a different ingredient entirely). If you use stabilized retinol (e.g., encapsulated retinol or a retinol-containing oil), the label must identify the stabilization vehicle as well (e.g., "Retinol," "Squalane (Retinol)," or "Caprylic/Capric Triglyceride (Retinol)" depending on the formulation). The preservative system (e.g., phenoxyethanol, sodium benzoate, potassium sorbate) must also be listed by INCI name at the concentration level. If you add additional actives (peptides, niacinamide, resveratrol), they must all appear in the ingredient list with their INCI names. A common mistake is listing "Natural Retinol Extract" or "Bakuchiol from Babchi Plant"—the FDA and retailers expect standardized INCI names, and non-standard names raise questions during regulatory review.

Warning statements for retinol are not optional, and the FDA and FTC have cracked down on retinol brands that downplay irritation risk or fail to warn about photosensitivity. The warning must appear on the principal display panel (the front label, visible to consumers at point of sale) or the information panel (back label), and it must clearly state: (1) that the product may cause redness, peeling, or irritation; (2) to avoid contact with eyes; (3) to use sunscreen during daytime use (or "avoid sun exposure"); and (4) if irritation develops, to reduce frequency or discontinue. Language like "slight tingling sensation" or "mild adjustment period" is not a sufficient warning—you must use the word "irritation" or "peeling" to be compliant. Some brands add additional safety language such as "Not suitable for pregnant women" (because retinol is a teratogen in high systemic doses, though topical cosmetic-level retinol is considered low-risk) or "Consult a healthcare provider if you have sensitive skin." This additional language can help with liability but is not federally required for cosmetics (unlike for drug claims).

Marketing claims and substantiation are heavily regulated. If you claim that your serum "reduces fine lines," "smooths skin," or "promotes skin renewal," you must have substantiation: this can be a clinical study (typically a 4–8 week double-blind, placebo-controlled human study with 20+ participants), consumer perception data (user surveys or before-and-after photos), or published literature on retinol efficacy. You cannot claim "reduces wrinkles" or "anti-aging" without substantiation, and the FTC and FDA do not consider ingredient efficacy literature alone to be sufficient unless the literature is specifically about the exact formula you are selling. A common pitfall is claiming benefits that cross into drug territory. For example, "reduces the appearance of fine lines" is a cosmetic claim (acceptable); "treats wrinkles" is a drug claim (requires drug approval, which retinol serums do not have). If you claim "helps reduce signs of aging," you are on the cosmetic side; if you claim "reverses aging" or "prevents aging," the FDA may challenge you. The safest claims for a retinol serum are: "supports skin renewal," "nourishes skin," "helps improve the appearance of skin texture," or "made with retinol (a known antioxidant)." These are descriptive rather than therapeutic and are less likely to trigger FDA scrutiny.

The cosmetic vs. drug classification is critical. A retinol serum is classified as a cosmetic as long as you do not claim it treats, mitigates, or prevents any disease or condition. Retinol is a regulated cosmetic ingredient (listed in 21 CFR Part 700.11), meaning it is permitted in cosmetics but must be used in concentrations and contexts that do not pose safety concerns. The FDA does not mandate a maximum concentration for retinol in cosmetics (unlike sunscreen actives, which have a drug monograph), but industry practice is to keep retinol below 2% in leave-on serums to avoid excessive irritation risk. If you use retinol above 2% or if you claim the serum "treats acne" or "reduces acne lesions," the FDA may reclassify your product as a drug, which requires submission of a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA)—a process that takes months or years and is rarely pursued for indie brands. The safest approach is to stay under 1% retinol (or retinyl palmitate), avoid disease or condition claims, and focus on cosmetic benefits like appearance and skin feel.

Bakuchiol has no specific FDA regulatory restrictions, but it is not permitted as a drug active in the USA (unlike retinol's gray area). Bakuchiol is used as a cosmetic ingredient and is not a regulated drug active. If you claim bakuchiol "reduces wrinkles as effectively as retinol," you are making a comparative cosmetic claim that must be substantiated, but you are not crossing into drug territory. The claim is permissible if you have data showing bakuchiol improves the appearance of wrinkles.

Label format and information panel placement are mandated by the FDA. The principal display panel (PDP) must include: (1) product identity (e.g., "Bakuchiol Retinol Serum"); (2) net quantity of contents (e.g., "30 mL" or "1 FL OZ"); and (3) warning or caution statements for retinol. The information panel (typically the back or side) must include: (1) the full ingredient list ("Ingredients:"); (2) the manufacturer or distributor's name and address; and (3) directions for use (e.g., "Apply 2–3 drops to clean skin at night. Follow with moisturizer. Use SPF 30+ during the day."). All text must be in English and in a font size that is legible (generally at least 1/16 inch for most text, with some exemptions for very small packages). If your label is very small, you may be allowed a "information leaflet" or QR code linking to full details, but the warning statement must appear on the package itself.

You must also establish a regulatory responsible party (a USA-based person or company name, with an address) to appear on the label. If you are importing from a foreign manufacturer or if your manufacturer is in Canada or Mexico, you (the brand owner or a USA distributor) must be listed as the responsible party. This person/company is responsible for compliance and is the contact point if the FDA needs to reach someone about the product.

Standardized product liability information should be maintained by your manufacturer, including a completed Safety Data Sheet (SDS) for each raw ingredient (retinol, bakuchiol, preservatives, etc.), test reports confirming the formula is safe and shelf-stable, microbial testing results, and retinol potency assay results. While you do not submit these to the FDA upfront (cosmetics are not pre-approved), you must have them available if the FDA requests them or if you face a liability claim.

When working with your manufacturer on the AJ Cosmo Labs platform, confirm that they understand these regulatory requirements and that they will provide label copy suggestions and review your marketing claims before production. A reputable manufacturer will flag claims that are overstated or may trigger regulatory scrutiny. They will also ensure that your formula does not contain banned cosmetic ingredients (like mercury, lead, or cadmium) and that all additives comply with 21 CFR Part 700. Finally, establish a relationship with a cosmetic regulatory consultant or attorney if you are unsure about claim substantiation or labeling—the cost ($500–$2,000) is well worth avoiding an FDA warning letter or product recall.

Ingredients in this answer: Bakuchiol · Retinol · Caprylic/Capric Triglyceride · Retinyl Palmitate · Squalane

Read the full guide on Private Label Bakuchiol Retinol Serum Manufacturer USA →

More about Private Label Bakuchiol Retinol Serum Manufacturer USA

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app